Emerging technologies in the journey to HCP engagement
In an exclusive interview with SciencePOD, Sarah Christensen of Novartis unveils the future of HCP engagement through data-driven, personalised communication and cutting-edge AI technologies, ahead of her panel at Reuters Events: Pharma 2024.